Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
53.1%
% of ARKG's 34 holdings also in WDNA
20.2%
% of WDNA's 90 holdings also in ARKG
Overlap by Weight
Sector Drift (ARKG minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ARKG |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 5.2% | 4.3% | 4.3% |
|
TWIST BIOSCIENCE CORP. | 7.4% | 3.7% | 3.7% |
|
VERACYTE INC | 4.0% | 2.5% | 2.5% |
|
BEAM THERAPEUTICS, INC. | 4.5% | 1.5% | 1.5% |
|
AMGEN INC | 1.6% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
ARKG Overweight Relative to WDNA
|
RECURSION PHARMACEUTICALS, INC CLASS | 8.8% |
|
CRISPR THERAPEUTICS AG | 6.4% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | 5.0% |
|
GUARDANT HEALTH, INC. | 4.7% |
|
CAREDX, INC. | 4.3% |
|
TWIST BIOSCIENCE CORP. | 3.7% |
|
SCHRODINGER, INC. | 3.1% |
|
BEAM THERAPEUTICS, INC. | 3.0% |
|
ABSCI CORPORATION | 2.9% |
|
INTELLIA THERAPEUTICS, INC. | 2.6% |
ARKG Underweight Relative to WDNA
|
VERICEL CORPORATION | -2.7% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
ELI LILLY & CO | -2.4% |
|
BRIDGEBIO PHARMA, INC. | -2.4% |
|
UNITED THERAPEUTICS CORP | -1.9% |
|
AGIOS PHARMACEUTICALS INC | -1.8% |
|
ALNYLAM PHARMACEUTICALS INC | -1.6% |
|
GERON CORP | -1.6% |
|
GILEAD SCIENCES INC | -1.6% |